Mar 31, 2022 | Press Releases
Company to Host Conference Call Today at 4:30pm ET; Slide Presentation Also Available SARASOTA, Fla., March 31, 2022 — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on...
Mar 24, 2022 | Press Releases
Financial results to be released after market close; Conference call to be conducted at 4:30 pm ET SARASOTA, Fla., March 24, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment...
Mar 24, 2022 | Press Releases
SARASOTA, Fla., March 24, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available, is exhibiting the INVOcell solution at the 2022 Pacific Coast Reproductive Society...
Mar 22, 2022 | Press Releases
SARASOTA, Fla., March 22, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the IVC procedure it enables, announced today that...
Mar 10, 2022 | Press Releases
SARASOTA, Fla., March 10, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), developers of the INVOcell®, an advanced fertility treatment technology which is currently available through a number of channels, including its new joint-venture owned INVO Center in...
Feb 16, 2022 | Press Releases
Tampa INVO Center to focus on advanced fertility care utilizing INVOcell®SARASOTA, Fla. and TAMPA, Fla., Feb. 16, 2022 — INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide...
